Personalized Medicine Market Research Reports & Industry Analysis
Personalized medicine is transforming how we approach medical treatments and patient care by offering greater accuracy, efficacy, and safety. MarketResearch.com provides a selection of reports on the personalized medicine and precision medicine industry to help you get up to speed quickly and build effective long-term strategies in this space.
Precision and Personalized Medicine Market Data
- Use our reports to understand key technologies, use cases, regulatory trends, deals, and other critical topics.
- Gain access to personalized medicine market sizing and growth forecasts, as well as value chain analysis.
- Read expert predictions about how the market will evolve and identify the companies most likely to weather disruptive threats.
Trusted Expertise
Whether you are exploring new markets or advising an important client, our reports serve as a practical guide to inform your decisions. With a dedication to delivering quality research from top market research firms globally, MarketResearch.com has been a reliable partner for organizations throughout the value chain for decades. Browse our list of personalized medicine market research reports to gain the knowledge needed for success.
Personalized Medicine Industry Research & Market Reports
-
Germany Artificial Intelligence (Ai) In Healthcare Market Forecast 2024-2032
... escalate the market growth, such as large volumes of healthcare data supporting the adoption of AI, a growing number of AI and machine learning start-ups, the emergence of personalized medicine in tests for clinical decision-making, ... Read More
-
Global Artificial Intelligence (Ai) In Healthcare Market Forecast 2024-2032
... elevate the market growth: large volumes of healthcare data supporting the adoption of AI, investments towards AI research & development coupled with proactive government support, a growing number of AI and machine learning start-ups, the ... Read More
-
India Artificial Intelligence (Ai) In Healthcare Market Forecast 2024-2032
... promote the market growth, such as large volumes of healthcare data supporting the adoption of AI, a growing number of AI and machine learning start-ups, the emergence of personalized medicine in tests for clinical decision-making, ... Read More
-
Next-Generation Sequencing Market Assessment, By Product [NGS Consumables, Presequencing Products and Services, Sequencing Services, NGS Platforms, Bioinformatics, Services for NGS Platforms], By Sequencing Type [RNA Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Targeted Resequencing, CHIP Sequencing, De Novo Sequencing, Methyl Sequencing, Others], By Technology [Sequencing by Synthesis, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Ion Semiconductor Sequencing, Others], By Application [Drug Discovery and Personalized Medicine, Diagnostics, Genetic Screening, Agriculture and Animal Research, Others], By End-user [Hospitals and Clinics, Academic Institutes and Research Centers, Pharmaceutical and Biotechnology Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
... Sequencing, De Novo Sequencing, Methyl Sequencing, Others], By Technology [Sequencing by Synthesis, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Ion Semiconductor Sequencing, Others], By Application [Drug Discovery and Personalized Medicine, Diagnostics, Genetic Screening, Agriculture and Animal Research, ... Read More
-
Cancer Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... 409.68 billion by 2029, growing at a CAGR of 10.64% during the forecast period (2024-2029). The factors driving the market's growth include increasing patient assistance programs (PAPs), increasing government initiatives for cancer awareness, the rising ... Read More
-
Tumor Profiling Market Size, Trends, Analysis, and Outlook By Cancer (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Others), By Biomarker, Genomic Biomarker, Protein Biomarker), By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), by Region, Country, Segment, and Companies, 2024-2030
... Mass Spectrometry, In-Situ Hybridization, Microarrays, Others), By Technique (Genomics, Proteomics, Metabolomics, Epigenetics), By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring), by Region, Country, Segment, and Companies, 2024-2030 The ... Read More
-
US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... CAGR of 4.62%, over the period 2024-2028. The factors such as increasing geriatric population, growing burden of chronic diseases, escalating penetration of electronic health record (EHR) systems, hike in healthcare expenditure and expanding urbanization would ... Read More
-
Organoids and Spheroids Market Size, Trends, Analysis, and Outlook Organoids By Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Others), Organoids By Method (General Submerged Method for Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), Spheroids By Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Spheroids By Source (Cell Line, Primary Cell, iPSCs Derived Cells), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing), By End-user (Biotechnology and pharmaceutical industries, Academic & Research Institutes, Hospitals and diagnostic cente
... (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), ... Read More
-
Healthcare Bioconvergence Market Size, Trends, Analysis, and Outlook By Application (Drug Discovery, Nanorobotics for Drug Delivery, Regenerative Medicine, Diagnostic and Biological Senso, Bioelectronics, Engineered Living Materials, Optogenetics, Precision Medicine), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Healthcare Bioconvergence market size is poised to register 7.18% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Healthcare Bioconvergence ... Read More
-
The 2025-2030 World Outlook for Cellular Health Screenings
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Personalized Retail Nutrition and Wellness
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Predictive Healthcare Analytics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Cellular Health Screening-Health Testing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Personalized Medicine and Epigenomics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Precision Medicine (Diagnostics-Therapeutics)
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Precision Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Precision Medicine Software
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Personalized Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Tests and Lab Services for Personalized Medicines
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Single-Test Panels for Cellular Health Screening and Health Testing
... For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032
... and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032 The global biomarkers market size reached US$ 79.9 Billion in 2023. Looking forward, IMARC ... Read More
-
North America DNA Sequencing Products Market Report by Product Type (Consumables and Reagents, Equipment), Application (Biomarkers, Diagnostics, Reproductive Health, Forensics, Personalized Medicine, and Others), End-User (Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Country 2024-2032
... and Clinics, and Others), and Country 2024-2032 The North America DNA sequencing products market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.3 Billion by 2032, ... Read More
-
Next-Generation Sequencing (NGS) Market Report by Sequencing Type (Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, CHIP Sequencing, De Novo Sequencing, Methyl Sequencing, and Others), Product Type (Instruments, Reagents and Consumables, Software and Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, and Others), Application (Biomarker and Cancer, Drug Discovery and Personalized Medicine, Genetic Screening, Diagnostics, Agriculture and Animal Research, and Others), End-User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others), and Region 2024-2032
... Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, and Others), Application (Biomarker and Cancer, Drug Discovery and Personalized Medicine, Genetic Screening, Diagnostics, Agriculture and Animal Research, and Others), End-User (Academic ... Read More
-
Personalized Medicine Global Market Report 2024
... End-use: Hospitals; Diagnostic Centers; Research and Academic InstitutesCovering: Bayer AG; Novartis AG; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc; AstraZeneca plc Personalized Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and ... Read More
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
... to reach USD 5.8 billion by 2028 from an estimated USD 3.5 billion in 2023, at a CAGR of 10.6% during the forecast period. The growth of this market can be attributed to the research ... Read More
Research Assistance
